BBK Worldwide Recognized Among World's Most Disruptive Pharma Services Innovators

BBK Worldwide Recognized Among World's Most Disruptive Pharma Services Innovators

Posted by Elizabeth Gargill on Tue, Feb 16, 2021




BBK Worldwide Featured in Newly Published Innovations in Pharmaceutical Development


Guide Provides In-Depth Profiles of World’s Most Disruptive Pharma Services Innovators

BBK Worldwide has been recognized as a top innovator in Innovations in Pharmaceutical Development™. This newly published guide highlights the companies and thought leaders at the forefront of innovation in the pharmaceutical development space. 

Commissioned by Crosstree, an investment banking firm focused on the needs of middle-market companies within the life sciences and healthcare industries, Innovations in Pharmaceutical Development™ provides readers with in-depth profiles and bottom-up analysis of the companies forging the future of pharma development.


BBK was selected by a panel of six independent industry experts and three panelists from Crosstree, and is recognized among the 15 Clinical Services innovators for its efforts to push the industry forward with its game-changing tools and technologies that enroll and engage patients in clinical trials.

BBK’s first-in-class patient experience management system TrialCentralNet® (TCN®) is highlighted for revolutionizing the management of clinical trial recruitment, enrollment, and engagement. BBK is also recognized for its long-standing commitment to removing barriers to clinical trial participation and increasing access to care with solutions that include RSG® Card and RSG® Arrive – the company’s signature reimbursement and travel programs.

Innovations in Pharmaceutical Development™ can be downloaded here for $100. Hard copies can be ordered here for $125. 



Topics: TrialCentralNet, Patient Experience, Most Viewed, Clinical Trial Innovations, Innovations in Pharmaceutical Development